Viewing nowCombinationZadim Duo Tablet 12.5/850 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.

MFDS item code 202302746 · Approved 2023.09.13 · Insurance code 694004420
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to help control blood sugar in adults with type 2 diabetes. When taken alongside dietary changes and exercise, it can effectively reduce blood sugar levels. It can also be administered to patients with cardiovascular disease; however, it is important to follow the guidance of a healthcare professional in such cases. This medication contributes to the prevention of diabetes-related complications by improving blood sugar management.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient’s current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who are unable to achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and their current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take a double dose at one time; if this happens, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is required in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who have no other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual single-ingredient products of empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). Elderly patients For patients 75 years of age or older, renal function and the risk of volume depletion should be considered.
This medication is used to treat diabetes and helps in controlling blood sugar levels. It should not be administered to patients with impaired kidney function or those with severe infections or dehydration. It is safest for pregnant or breastfeeding women to avoid this medication. Hypoglycemia may occur during treatment; caution is needed when taking alongside insulin or other blood sugar-lowering agents. Additionally, this medication can rarely cause a serious metabolic disturbance called lactic acidosis, so if symptoms such as sudden muscle pain, difficulty breathing, or weakness occur, contact a doctor immediately. There is a risk of urinary tract infections or genital infections, so appropriate treatment should be received if infection symptoms appear. If surgery is planned or if undergoing procedures using radiographic contrast agents, this medication should be discontinued for a period of time, and it should be resumed only after verifying normal kidney function. Elderly patients or those with compromised kidney function should regularly monitor kidney function and adjust the dosage accordingly. It is advisable to avoid alcohol during treatment and to use this medication with caution in situations where there is a risk of fluid loss. This medication may lower Vitamin B12 levels; thus, routine blood tests to check vitamin levels are recommended during long-term use. Moreover, various side effects may occur; if any unusual symptoms arise, consult a healthcare professional immediately.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to prevent air and moisture exposure, at a temperature between 1 to 30 degrees Celsius. This way of storing will help maintain the effectiveness of the medication for a longer period.
Pink-tinted, white, double-convex oval film-coated tablet
60 tablets/box (10 tablets/PTP x 6), 10 tablets/box (10 tablets/PTP x 1), 60 tablets/bottle, 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.